BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22852092)

  • 1. Early detection of maternal risk for preeclampsia.
    Mikat B; Gellhaus A; Wagner N; Birdir C; Kimmig R; Köninger A
    ISRN Obstet Gynecol; 2012; 2012():172808. PubMed ID: 22852092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model for screening for early-onset preeclampsia.
    Serra B; Mendoza M; Scazzocchio E; Meler E; Nolla M; Sabrià E; Rodríguez I; Carreras E
    Am J Obstet Gynecol; 2020 Jun; 222(6):608.e1-608.e18. PubMed ID: 31972161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume.
    Sonek J; Krantz D; Carmichael J; Downing C; Jessup K; Haidar Z; Ho S; Hallahan T; Kliman HJ; McKenna D
    Am J Obstet Gynecol; 2018 Jan; 218(1):126.e1-126.e13. PubMed ID: 29097177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary.
    Orosz L; Orosz G; Veress L; Dosa D; Orosz L; Arany I; Fabian A; Medve L; Pap K; Karanyi Z; Toth Z; Poka R; Than NG; Torok O
    J Biotechnol; 2019 Jul; 300():11-19. PubMed ID: 31055145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation.
    Wright A; Wright D; Syngelaki A; Georgantis A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Feb; 220(2):197.e1-197.e11. PubMed ID: 30414394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review.
    Kuc S; Wortelboer EJ; van Rijn BB; Franx A; Visser GH; Schielen PC
    Obstet Gynecol Surv; 2011 Apr; 66(4):225-39. PubMed ID: 21756405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
    Konchak PS; Bernstein IM; Capeless EL
    Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Screening for small-for-gestational age neonates at early third trimester in a high-risk population for preeclampsia".
    Mula R; Meler E; García S; Albaigés G; Serra B; Scazzocchio E; Prats P
    BMC Pregnancy Childbirth; 2020 Sep; 20(1):563. PubMed ID: 32988372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopplerography in the diagnosis of preeclampsia in the second trimester of pregnancy.
    Ghoghoberidze S; Labartkava A; Geladze T; Geladze K; Gabidzashvili D
    Georgian Med News; 2008 Jun; (159):18-21. PubMed ID: 18633145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model.
    Agarwal R; Chaudhary S; Kar R; Radhakrishnan G; Tandon A
    J Obstet Gynaecol; 2017 Oct; 37(7):877-882. PubMed ID: 28569565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of early supplementation with low-dose aspirin on functional first trimester parameters in low-risk pregnancies.
    Zvanca ME; Bot M; Radu D; Radu N; Petca A
    J Matern Fetal Neonatal Med; 2019 Feb; 32(4):604-609. PubMed ID: 28974130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP086. The modern search for possible predictors of preeclampsia in the first trimester of pregnancy (preliminary study).
    Khodzhaeva ZS; Ivanets TY; Alexeeva ML; Kholin AM; Akatyeva AS; Vavina OV; Sukhikh GT
    Pregnancy Hypertens; 2012 Jul; 2(3):287. PubMed ID: 26105408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FIRST-TRIMESTER ULTRASOUND AND BIOCHEMICAL MARKERS AND THEIR PREDICTIVE RATE IN PREECLAMPSIA DEVELOPMENT].
    Chalova K; Pehlivanov B
    Akush Ginekol (Sofiia); 2015; 54(4):46-51. PubMed ID: 26410947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.